C-2: THE SECOND INJECTION

 The second injection is the one actually responsible for the growth of nerve cells, and therefore contains the proteins that spur the enzymatic chain of reactions responsible for embryonic cell growth.

Once the proteins are successfully marked and the MAG destroyed as a result of the first injection, the second injection, C-2, is administered. As demonstrated by various experiments in recent years, an increase in the amount of the receptor proteins GPR3, GPR6, and GPR12 can increase the production of cAMP in the body. These proteins, found inside the C-2 capsule, bind to the cells marked by C-1 and tell the body to produce cAMP, the enzyme that controls axonal growth in embryos.

Once the cell growth has been initiated, the myelin sheath reforms. During the nerve development process, a fourth protein in the C-2 injection destroys the MAG antibodies from C-1, thereby preventing the onset of other problems.

Because the process by which the axons are re-grown is the same process by which the nerve cells were initially formed, the cells form new connections as part of their development process.

Just as the formation of connections continues through the first few years of life as a result of outside stimuli, the now possible use of previously paralyzed or damaged limbs will continually strengthen connections until all previous functions are restored.

Instead of complex surgeries or a lifetime with paralysis, two specific and targeted injections can change the lives of individuals with nerve damage.

return to first CONNECT injection

Click HERE to watch the CONNECT prototype in action!